Skip to content
10-Q

Quarterly Report

Targeted Medical Pharma, Inc.

0001493152-14-003731

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 13, 2014 26.55M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 −$8.71M
Stockholders Equity Q3 2014 · Dec 31, 2013 −$7.02M
Current Liabilities Q3 2014 · Sep 30, 2014 $11.53M
Current Liabilities Q3 2014 · Dec 31, 2013 $11.26M
Total Liabilities Q3 2014 · Sep 30, 2014 $11.93M
Total Liabilities Q3 2014 · Dec 31, 2013 $12.02M
Current Assets Q3 2014 · Sep 30, 2014 $1.16M
Current Assets Q3 2014 · Dec 31, 2013 $2.63M
Stock Issued Q3 2014 · Jul 9, 2014 130K sh
Stock Issued Q3 2014 · Mar 31, 2014 281.67K sh
Total Assets Q3 2014 · Dec 31, 2013 $5M
Total Assets Q3 2014 · Sep 30, 2013 $4.93M
Capex Q3 2014 · Sep 30, 2013 $27.28K
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$170.2K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $167.87K
Cash And Equivalents Q3 2014 · Dec 31, 2012 $326.6K
Sga Expense Q3 2014 · Sep 30, 2013 $2.96M
Sga Expense Q3 2014 · Sep 30, 2013 $8.32M
Rd Expense Q3 2014 · Sep 30, 2013 $103.6K
Rd Expense Q3 2014 · Sep 30, 2013 $169.72K
Net Income Q3 2014 · Sep 30, 2013 −$1.72M
Net Income Q3 2014 · Sep 30, 2013 −$9.83M
Operating Income Q3 2014 · Sep 30, 2013 −$1.5M
Operating Income Q3 2014 · Sep 30, 2013 −$3.83M
Gross Profit Q3 2014 · Sep 30, 2013 $1.56M
Gross Profit Q3 2014 · Sep 30, 2013 $4.66M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $633.07K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $2.27M
Revenue Q3 2014 · Sep 30, 2013 $2.19M
Revenue Q3 2014 · Sep 30, 2013 $6.92M